BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24332014)

  • 1. High activities of BACE1 in brains with mild cognitive impairment.
    Cheng X; He P; Lee T; Yao H; Li R; Shen Y
    Am J Pathol; 2014 Jan; 184(1):141-7. PubMed ID: 24332014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment.
    Zhong Z; Ewers M; Teipel S; Bürger K; Wallin A; Blennow K; He P; McAllister C; Hampel H; Shen Y
    Arch Gen Psychiatry; 2007 Jun; 64(6):718-26. PubMed ID: 17548753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
    Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
    Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.
    Zetterberg H; Andreasson U; Hansson O; Wu G; Sankaranarayanan S; Andersson ME; Buchhave P; Londos E; Umek RM; Minthon L; Simon AJ; Blennow K
    Arch Neurol; 2008 Aug; 65(8):1102-7. PubMed ID: 18695061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.
    Zhao J; Fu Y; Yasvoina M; Shao P; Hitt B; O'Connor T; Logan S; Maus E; Citron M; Berry R; Binder L; Vassar R
    J Neurosci; 2007 Apr; 27(14):3639-49. PubMed ID: 17409228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum beta-secretase 1 (BACE1) activity increases in patients with mild cognitive impairment.
    Zuliani G; Trentini A; Brombo G; Rosta V; Guasti P; Romagnoli T; Polastri M; Marabini L; Pedrini D; Pistolesi C; Pacifico S; Guerrini R; Seripa D; Cervellati C
    J Neurochem; 2021 Nov; 159(3):629-637. PubMed ID: 34534363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains.
    Harada H; Tamaoka A; Ishii K; Shoji S; Kametaka S; Kametani F; Saito Y; Murayama S
    Neurosci Res; 2006 Jan; 54(1):24-9. PubMed ID: 16290302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease.
    Lei X; Lei L; Zhang Z; Zhang Z; Cheng Y
    Int J Clin Exp Pathol; 2015; 8(2):1565-74. PubMed ID: 25973041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of BACE1 and beta-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease.
    Zhiyou C; Yong Y; Shanquan S; Jun Z; Liangguo H; Ling Y; Jieying L
    Neurochem Res; 2009 Jul; 34(7):1226-35. PubMed ID: 19123057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered γ-secretase activity in mild cognitive impairment and Alzheimer's disease.
    Kakuda N; Shoji M; Arai H; Furukawa K; Ikeuchi T; Akazawa K; Takami M; Hatsuta H; Murayama S; Hashimoto Y; Miyajima M; Arai H; Nagashima Y; Yamaguchi H; Kuwano R; Nagaike K; Ihara Y;
    EMBO Mol Med; 2012 Apr; 4(4):344-52. PubMed ID: 22354516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer's Disease.
    Nicsanu R; Cervellati C; Benussi L; Squitti R; Zanardini R; Rosta V; Trentini A; Ferrari C; Saraceno C; Longobardi A; Bellini S; Binetti G; Zanetti O; Zuliani G; Ghidoni R
    J Alzheimers Dis; 2022; 87(1):433-441. PubMed ID: 35275540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.
    Hampel H; Shen Y
    Scand J Clin Lab Invest; 2009; 69(1):8-12. PubMed ID: 18609117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BACE1 levels by APOE genotype in non-demented and Alzheimer's post-mortem brains.
    Decourt B; Gonzales A; Beach TG; Malek-Ahmadi M; Walker A; Sue L; Walker DG; Sabbagh MN
    Curr Alzheimer Res; 2013 Mar; 10(3):309-15. PubMed ID: 23036023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI).
    Bermejo-Bescós P; Martín-Aragón S; Jiménez-Aliaga K; Benedí J; Felici E; Gil P; Ribera JM; Villar AM
    Neurochem Res; 2013 Jul; 38(7):1415-23. PubMed ID: 23575575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-trans-retinoic acid reduces BACE1 expression under inflammatory conditions via modulation of nuclear factor κB (NFκB) signaling.
    Wang R; Chen S; Liu Y; Diao S; Xue Y; You X; Park EA; Liao FF
    J Biol Chem; 2015 Sep; 290(37):22532-42. PubMed ID: 26240147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer's Disease.
    De Vos A; Struyfs H; Jacobs D; Fransen E; Klewansky T; De Roeck E; Robberecht C; Van Broeckhoven C; Duyckaerts C; Engelborghs S; Vanmechelen E
    J Alzheimers Dis; 2016 Jul; 53(4):1523-38. PubMed ID: 27392859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal Fluid BACE1 Activity and sAβPPβ as Biomarker Candidates of Alzheimer's Disease.
    Alexopoulos P; Thierjung N; Grimmer T; Ortner M; Economou P; Assimakopoulos K; Gourzis P; Politis A; Perneczky R;
    Dement Geriatr Cogn Disord; 2018; 45(3-4):152-161. PubMed ID: 29788013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered beta-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer's disease brain.
    Stockley JH; Ravid R; O'Neill C
    FEBS Lett; 2006 Dec; 580(28-29):6550-60. PubMed ID: 17113083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease.
    Chen CH; Zhou W; Liu S; Deng Y; Cai F; Tone M; Tone Y; Tong Y; Song W
    Int J Neuropsychopharmacol; 2012 Feb; 15(1):77-90. PubMed ID: 21329555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target.
    Syeda T; Cannon JR
    J Biochem Mol Toxicol; 2021 Apr; 35(4):e22694. PubMed ID: 33393683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.